Page last updated: 2024-10-21

ibotenic acid and Developmental Disabilities

ibotenic acid has been researched along with Developmental Disabilities in 2 studies

Ibotenic Acid: A neurotoxic isoxazole (similar to KAINIC ACID and MUSCIMOL) found in AMANITA mushrooms. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist.

Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhardwaj, SK1
Tse, YC1
Ryan, R1
Wong, TP1
Srivastava, LK1
Lee, H1
Dvorak, D1
Kao, HY1
Duffy, ÁM1
Scharfman, HE1
Fenton, AA1

Other Studies

2 other studies available for ibotenic acid and Developmental Disabilities

ArticleYear
Impaired adrenergic-mediated plasticity of prefrontal cortical glutamate synapses in rats with developmental disruption of the ventral hippocampus.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:13

    Topics: Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Conditioning, Psychological; Developmental

2014
Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model.
    Neuron, 2012, Aug-23, Volume: 75, Issue:4

    Topics: Animals; Animals, Newborn; Avoidance Learning; Brain Waves; Cell Count; Cognition Disorders; Cogniti

2012